Prospective analysis of pulmonary hypertension in extremely low birth weight infants

Pediatrics

Volumn 129, Issue 3, 2012, Pages

  Bhat, Ramachandra ^a   Salas, Ariel A ^a   Foster, Chris ^b   Carlo, Waldemar A ^a   Ambalavanan, Namasivayam ^a  

^a University of Alabama at Birmingham   (United States)

^b Alpine Pediatrics   (United States)

Author keywords

Bronchopulmonary dysplasia; Premature infant; Pulmonary hypertension

Indexed keywords

BOSENTAN; NITRIC OXIDE; OXYGEN; PROSTACYCLIN; SILDENAFIL;

ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; CHILD HOSPITALIZATION; CHRONIC LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EXTREMELY LOW BIRTH WEIGHT; FEMALE; GESTATIONAL AGE; HEALTH CARE MANAGEMENT; HEART RIGHT VENTRICLE FAILURE; HUMAN; INFANT; INFANT MORTALITY; INTERMITTENT MANDATORY VENTILATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OXYGEN SATURATION; OXYGEN THERAPY; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SURVIVAL TIME; SURVIVOR;

EID: 84857937329     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-1827     Document Type: Article

References (23)

1. Stoll BJ, Hansen NI, Bell EF, et al Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126(3):443-456
2. Subhedar NV. Recent advances in diagnosis and management of pulmonary hypertension in chronic lung disease. Acta Paediatr Suppl. 2004;93(444):29-32 (Pubitemid 38230444)
3. Abman SH. Monitoring cardiovascular function in infants with chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed. 2002;87(1):F15-F18 (Pubitemid 34753789)
4. Gorenflo M, Vogel M, Obladen M. Pulmonary vascular changes in bronchopulmonary dysplasia: a clinicopathologic correlation in short- and long-term survivors. Pediatr Pathol. 1991;11(6):851-866
5. Stenmark KR, Abman SH. Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. Annu Rev Physiol. 2005;67:623-661 (Pubitemid 40404504)
6. Thébaud B. Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity. Neonatology. 2007;91(4):291-297 (Pubitemid 46934214)
7. Fouron JC, Le Guennec JC, Villemant D, Perreault G, Davignon A. Value of echocardiography in assessing the outcome of bronchopulmonary dysplasia of the newborn. Pediatrics. 1980;65(3):529-535 (Pubitemid 10147587)
8. Halliday HL, Dumpit FM, Brady JP. Effects of inspired oxygen on echocardiographic assessment of pulmonary vascular resistance and myocardial contractility in bronchopulmonary dysplasia. Pediatrics. 1980;65(3):536-540 (Pubitemid 10147588)
9. An HS, Bae EJ, Kim GB, et al. Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Korean Circ J. 2010;40(3):131-136
10. Slaughter JL, Pakrashi T, Jones DE, South AP, Shah TA. Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation. J Perinatol. 2011; 31(10):635-640
11. Farquhar M, Fitzgerald DA. Pulmonary hypertension in chronic neonatal lung disease. Paediatr Respir Rev. 2010;11(3):149-153
12. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163(7):1723-1729 (Pubitemid 32578778)
13. Walsh MC, Yao Q, Gettner P, et al National Institute of Child Health and Human Development Neonatal Research Network. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics. 2004;114(5):1305-1311 (Pubitemid 41647693)
14. Mourani PM, Sontag MK, Younoszai A, Ivy DD, Abman SH. Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease. Pediatrics. 2008;121(2):317-325 (Pubitemid 351198454)
15. Khemani E, McElhinney DB, Rhein L, et al. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics. 2007;120(6):1260-1269 (Pubitemid 350223677)
16. Poets CF, Stebbens VA, Richard D, Southall DP. Prolonged episodes of hypoxemia in preterm infants undetectable by cardiorespiratory monitors. Pediatrics. 1995;95(6):860-863
17. Bolivar JM, Gerhardt T, Gonzalez A, et al. Mechanisms for episodes of hypoxemia in preterm infants undergoing mechanical ventilation. J Pediatr. 1995;127(5):767-773
18. Dimaguila MA, Di Fiore JM, Martin RJ, Miller MJ. Characteristics of hypoxemic episodes in very low birth weight infants on ventilatory support. J Pediatr. 1997;130(4):577-583 (Pubitemid 27492649)
19. Danhaive O, Margossian R, Geva T, Kourembanas S. Pulmonary hypertension and right ventricular dysfunction in growth-restricted, extremely low birth weight neonates. J Perinatol. 2005;25(7):495-499 (Pubitemid 40975602)
20. Banks BA, Seri I, Ischiropoulos H, Merrill J, Rychik J, Ballard RA. Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia. Pediatrics. 1999;103(3):610-618 (Pubitemid 29274509)
21. Mourani PM, Sontag MK, Ivy DD, Abman SH. Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease. J Pediatr. 2009;154(3):379-384
22. Krishnan U, Krishnan S, Gewitz M. Treatment of pulmonary hypertension in children with chronic lung disease with newer oral therapies. Pediatr Cardiol. 2008;29(6):1082-1086
23. Rugolotto S, Errico G, Beghini R, Ilic S, Richelli C, Padovani EM. Weaning of epoprostenol in a small infant receiving concomitant bosentan for severe pulmonary arterial hypertension secondary to bronchopulmonary dysplasia. Minerva Pediatr. 2006;58(5):491-494 (Pubitemid 44690319)